Red Tree Venture Capital
Overview
Red Tree Venture Capital is an early stage-biased life science venture firm that employs a targeted strategy of leveraging its deep relationships with leading West Coast academic and research institutions to source innovation emerging from those organizations . The firm focuses primarily on entrepreneurs developing first-in-class and/or best-in-class therapeutics addressing significant unmet needs in the areas of oncology, neurology, and immunology .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Bicara Therapeutics | Dec 2023 | Series C | Co-investor |
| Cargo Therapeutics | Mar 2023 | Series A | - |
| Magnus Medical | May 2025 | Series B | Co-investor |
| Engrail Therapeutics | Mar 2024 | Series B | Co-investor |
| BioGraph 55 | Jun 2024 | Series B | Co-investor |
For institutional investors. Book with your work email.
Key People
Cassie Lue
Vice President Of Investor Relations
Jeremy Caldwell
Partner, Red Tree Venture Capital
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Red Tree Venture Capital based?
Red Tree Venture Capital is headquartered in Redwood City, California, United States.
When was Red Tree Venture Capital founded?
Red Tree Venture Capital was founded in 2020.
How many portfolio companies does Red Tree Venture Capital have?
Red Tree Venture Capital has 11 portfolio companies in Caplight's dataset.
What are some companies in Red Tree Venture Capital's portfolio?
Portfolio companies visible on Caplight include Bicara Therapeutics, Cargo Therapeutics, Magnus Medical, Engrail Therapeutics, BioGraph 55.
What was Red Tree Venture Capital's most recent investment shown here?
Red Tree Venture Capital's most recent investment in this portfolio sample was in Magnus Medical in 2025.
What sectors does Red Tree Venture Capital focus on?
Red Tree Venture Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Red Tree Venture Capital focus on?
Red Tree Venture Capital typically invests at the Early stage.
What is Red Tree Venture Capital's AUM?
Red Tree Venture Capital's assets under management are estimated between $250.0M and $500.0M.